Insider Trading Alert - WMGI, JBLU And PRI Traded By Insiders

Friday, Oct. 9, 2015, 36 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $573.03 to $9,901,038.00.

Highlighted Stocks Traded by Insiders:

Wright Medical Group (WMGI) - FREE Research Report

Tracy Julie D, who is SVP & Chief Commun. Officer at Wright Medical Group, sold 3,607 shares at $20.37 on Oct. 9, 2015. Following this transaction, the SVP & Chief Commun. Officer owned 8,856 shares meaning that the stake was reduced by 28.94% with the 3,607-share transaction.

Lightman James, who is SVP, General Counsel & Secty at Wright Medical Group, sold 4,987 shares at $20.37 on Oct. 9, 2015. Following this transaction, the SVP, General Counsel & Secty owned 16,555 shares meaning that the stake was reduced by 23.15% with the 4,987-share transaction.

Cordell Kevin D, who is Pres., Lower Extremities & Bio at Wright Medical Group, sold 1,778 shares at $20.37 on Oct. 9, 2015. Following this transaction, the Pres., Lower Extremities & Bio owned 5,924 shares meaning that the stake was reduced by 23.08% with the 1,778-share transaction.

Griffin William L. Jr, who is SVP GM BioMimetic Therapeutics at Wright Medical Group, sold 3,405 shares at $20.37 on Oct. 9, 2015. Following this transaction, the SVP GM BioMimetic Therapeutics owned 67,721 shares meaning that the stake was reduced by 4.79% with the 3,405-share transaction.

Berry Lance A, who is Sr. VP & CFO at Wright Medical Group, sold 5,146 shares at $20.37 on Oct. 9, 2015. Following this transaction, the Sr. VP & CFO owned 57,950 shares meaning that the stake was reduced by 8.16% with the 5,146-share transaction.

Walker Jennifer S., who is SVP, Process Improvement at Wright Medical Group, sold 1,616 shares at $20.37 on Oct. 9, 2015. Following this transaction, the SVP, Process Improvement owned 36,368 shares meaning that the stake was reduced by 4.25% with the 1,616-share transaction.

Andrews Julie, who is VP & Chief Acctg. Officer at Wright Medical Group, sold 2,694 shares at $20.37 on Oct. 9, 2015. Following this transaction, the VP & Chief Acctg. Officer owned 12,260 shares meaning that the stake was reduced by 18.02% with the 2,694-share transaction.

Burrows Robert P. III, who is SVP, Supply Chain at Wright Medical Group, sold 473 shares at $20.37 on Oct. 9, 2015. Following this transaction, the SVP, Supply Chain owned 21,522 shares meaning that the stake was reduced by 2.15% with the 473-share transaction.

Porter Jonathan Wesley, who is SVP, Chief Compliance Officer at Wright Medical Group, sold 678 shares at $20.37 on Oct. 9, 2015. Following this transaction, the SVP, Chief Compliance Officer owned 1,057 shares meaning that the stake was reduced by 39.08% with the 678-share transaction.

The shares most recently traded at $20.80, up $0.43, or 2.05% since the insider transaction. Historical insider transactions for Wright Medical Group go as follows:

  • 4-Week # shares sold: 434
  • 12-Week # shares sold: 434
  • 24-Week # shares sold: 25,632

The average volume for Wright Medical Group has been 191,600 shares per day over the past 30 days. Wright Medical Group has a market cap of $1.1 billion and is part of the health care sector and health services industry. Shares are down 21.92% year-to-date as of the close of trading on Friday.

Wright Medical Group, Inc., a specialty orthopaedic company, provides extremity and biologic solutions that enable clinicians to alleviate pain and restore their patients' lifestyles worldwide. Currently, there is 1 analyst who rates Wright Medical Group a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WMGI - FREE

TheStreet Quant Ratings rates Wright Medical Group as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and generally high debt management risk. Get the full Wright Medical Group Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

JetBlue Airways (JBLU) - FREE Research Report

Peterson Joel Clinton, who is Director at JetBlue Airways, sold 14,276 shares at $25.39 on Oct. 9, 2015. Following this transaction, the Director owned 601,772 shares meaning that the stake was reduced by 2.32% with the 14,276-share transaction.

The shares most recently traded at $26.52, up $1.13, or 4.28% since the insider transaction. Historical insider transactions for JetBlue Airways go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares sold: 43,347
  • 24-Week # shares sold: 104,942

The average volume for JetBlue Airways has been 7.8 million shares per day over the past 30 days. JetBlue Airways has a market cap of $8.0 billion and is part of the services sector and transportation industry. Shares are up 64.56% year-to-date as of the close of trading on Friday.

JetBlue Airways Corporation, a passenger carrier company, provides air transportation services. As of December 31, 2014, the company operated a fleet of 13 Airbus A321 aircrafts, 130 Airbus A320 aircrafts, and 60 EMBRAER 190 aircrafts. The company has a P/E ratio of 18.9. Currently, there are 8 analysts who rate JetBlue Airways a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JBLU - FREE

TheStreet Quant Ratings rates JetBlue Airways as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full JetBlue Airways Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Primerica (PRI) - FREE Research Report

Kelly William A., who is President of Subsidiary at Primerica, sold 800 shares at $47.17 on Oct. 9, 2015. Following this transaction, the President of Subsidiary owned 27,836 shares meaning that the stake was reduced by 2.79% with the 800-share transaction.

The shares most recently traded at $47.85, up $0.68, or 1.42% since the insider transaction. Historical insider transactions for Primerica go as follows:

  • 4-Week # shares sold: 29,969
  • 12-Week # shares sold: 38,119
  • 24-Week # shares sold: 108,297

The average volume for Primerica has been 528,400 shares per day over the past 30 days. Primerica has a market cap of $2.4 billion and is part of the financial sector and insurance industry. Shares are down 11.78% year-to-date as of the close of trading on Friday.

Primerica, Inc., together with its subsidiaries, distributes financial products to middle income households in the United States and Canada. The company operates in three segments: Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. The stock currently has a dividend yield of 1.33%. The company has a P/E ratio of 14.4. Currently, there are 4 analysts who rate Primerica a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on PRI - FREE

TheStreet Quant Ratings rates Primerica as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, notable return on equity, increase in stock price during the past year and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full Primerica Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Trump, Microsoft, General Electric and Chick-fil-A - 5 Things You Must Know

Trump, Microsoft, General Electric and Chick-fil-A - 5 Things You Must Know

Did General Electric's Earnings Truly Silence the Critics?

Did General Electric's Earnings Truly Silence the Critics?

Microsoft Set for Record High Open as Cloud Sales Drive Earnings Blowout

Microsoft Set for Record High Open as Cloud Sales Drive Earnings Blowout

Three Key Takeaways From Healthcare Earnings Season

Three Key Takeaways From Healthcare Earnings Season

Trump: 'Ready to Go to $500 Billion' on China Tariffs to 'Make Things Right'

Trump: 'Ready to Go to $500 Billion' on China Tariffs to 'Make Things Right'